Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors
- PMID: 32794009
- PMCID: PMC7882005
- DOI: 10.1007/s11764-020-00925-4
Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors
Abstract
Purpose: Cancer survivors diagnosed at an early age remain at risk for cancer recurrence and other chronic diseases. This study assessed engagement in surveillance for recurrence, cancer screening, and other recommended preventive health services among breast and colorectal cancer survivors with early-onset disease (≤ 50 years) who were diagnosed in California.
Methods: Breast and colorectal cancer survivors diagnosed with early-onset cancer between 1999 and 2009 were identified through the California Cancer Registry, the state-based cancer registry, and surveyed. Multivariable regression analyses were used to assess correlates of receipt of cancer surveillance, cancer screening, and other preventive health services.
Results: Of the 497 survivors that were invited to participate in the study, 156 completed the survey for a response rate of 31%. The sample was 50 years of age on average (range 32-69 years) with a mean time since diagnosis of 9 years. The majority of the sample (71%) was a racial/ethnic minority (24% Latino, 15% African American, 29% Asian). Overall, 80% received appropriate surveillance for recurrence, and 72% received recommended screening for early detection of other cancers (breast, cervical, colorectal). Increasing age was associated with lower likelihood of early detection screening (adjusted odds ratio (aOR) 0.28, 95% confidence interval (CI) 0.11-0.69), and higher income was associated with a greater likelihood (aOR 4.89, 95% CI 1.62-14.81). Screening rates were highest for blood pressure (96%), cholesterol (86%), and diabetes (81%), followed by dental visits (64%) and flu vaccination (35%). Greater use of recommended preventive health services was associated with increasing age, female sex, higher education level, and having health insurance.
Conclusions: Although the majority of survivors received appropriate surveillance for recurrence, engagement in other preventive health services varied substantially.
Implications for cancer survivors: Efforts are needed to address gaps in the use of recommended cancer screening and preventive health services among cancer survivors, particularly survivors with early-onset disease who may be at increased risk for additional cancers and common chronic conditions over their lifetime.
Keywords: Cancer screening; Cancer surveillance; Cancer survivors; Minority groups; Preventive health services.
Conflict of interest statement
Similar articles
-
Physician visits and preventive care among Asian American and Pacific Islander long-term survivors of colorectal cancer, USA, 1996-2006.J Cancer Surviv. 2014 Mar;8(1):70-9. doi: 10.1007/s11764-013-0319-1. Epub 2013 Nov 5. J Cancer Surviv. 2014. PMID: 24190589 Free PMC article.
-
Preventive care in older cancer survivors.J Geriatr Oncol. 2015 Mar;6(2):85-92. doi: 10.1016/j.jgo.2014.12.003. Epub 2014 Dec 24. J Geriatr Oncol. 2015. PMID: 25547206 Free PMC article.
-
Use of Preventive Health Services Among Cancer Survivors in the U.S.Am J Prev Med. 2018 Dec;55(6):830-838. doi: 10.1016/j.amepre.2018.07.021. Epub 2018 Oct 21. Am J Prev Med. 2018. PMID: 30352719
-
Adherence to Guideline-Recommended cancer screening among Utah cancer survivors.Cancer Med. 2023 Feb;12(3):3543-3554. doi: 10.1002/cam4.5168. Epub 2022 Aug 27. Cancer Med. 2023. PMID: 36029153 Free PMC article.
-
Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors.J Cancer Surviv. 2019 Aug;13(4):512-522. doi: 10.1007/s11764-019-00771-z. Epub 2019 Jun 6. J Cancer Surviv. 2019. PMID: 31172430
Cited by
-
Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors.J Cancer Surviv. 2024 Apr;18(2):541-552. doi: 10.1007/s11764-022-01258-0. Epub 2022 Oct 10. J Cancer Surviv. 2024. PMID: 36217067 Free PMC article.
References
-
- American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2016–2017. Atlanta, GA: American Cancer Society. 2017.
Publication types
MeSH terms
Grants and funding
- HHSN261201800032C/CA/NCI NIH HHS/United States
- HHSN261201800009C/CA/NCI NIH HHS/United States
- NU58DP006344/DP/NCCDPHP CDC HHS/United States
- HHSN261201800015I/CA/NCI NIH HHS/United States
- TL1 TR000121/TR/NCATS NIH HHS/United States
- P30 CA016042/CA/NCI NIH HHS/United States
- U48 DP001934/SIP11-044/CC/CDC HHS/United States
- HHSN261201800032I/CA/NCI NIH HHS/United States
- P30 CA16042/CA/NCI NIH HHS/United States
- HHSN261201800015C/CA/NCI NIH HHS/United States
- T32 HS000046/HS/AHRQ HHS/United States
- TL1 TR001883/TR/NCATS NIH HHS/United States
- U48 DP001934/DP/NCCDPHP CDC HHS/United States
- HHSN261201800009I/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
